New Edge Advisors, LLC Collegium Pharmaceutical, Inc Transaction History

New Edge Advisors, LLC

  • $16 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$21.06 - $24.0 $1,705 - $1,944
-81 Reduced 37.33%
136 $2,000
Q1 2023

May 12, 2023
SELL
$23.0 - $29.88 $37,283 - $48,435
-1,621 Reduced 88.19%
217 $5,000
Q4 2022

Feb 14, 2023
BUY
$16.14 - $23.55 $29,665 - $43,284
1,838 New
1,838 $42,000

Others Institutions Holding COLL

# of Institutions
247
Shares Held
37.4M
Call Options Held
59.3K
Put Options Held
9.5K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email